Literature DB >> 7071084

Hyperbaric ethanol antagonism: role of temperature, blood and brain ethanol concentrations.

R D Malcolm, R L Alkana.   

Abstract

Three studies investigated the mechanism of hyperbaric ethanol antagonism. C57 Bl/6j mice were injected intraperitoneally with 3.6 g/kg ethanol and were exposed to 1-12 atmospheres absolute (ATA) helium-oxygen or to 1 ATA air at temperatures that offset the cooling effects of helium or helium and ethanol. Hyperbaric treatment significantly reduced sleep-time and increased wake-up brain ethanol concentrations compared to temperature matched controls. Treatment with 12 ATA helium-oxygen increased the brain ethanol concentration and the brain-blood ethanol ratio at 150 minutes after ethanol administration. These results exclude helium or pressure-induced changes in body temperature, rate of blood ethanol decline or distribution to the brain as mechanisms mediating the antagonism. The data support a membrane site of antagonism.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7071084     DOI: 10.1016/0091-3057(82)90169-1

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  4 in total

1.  Temperature dependence of ethanol depression in rats.

Authors:  D A Finn; D C Boone; R L Alkana
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Reduced lethality from ethanol or ethanol plus pentobarbital in mice exposed to 1 or 12 atmospheres absolute helium-oxygen.

Authors:  R D Malcolm; D A Finn; P J Syapin; R L Alkana
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 3.  Molecular targets and mechanisms for ethanol action in glycine receptors.

Authors:  Daya I Perkins; James R Trudell; Daniel K Crawford; Ronald L Alkana; Daryl L Davies
Journal:  Pharmacol Ther       Date:  2010-04-23       Impact factor: 12.310

4.  Hyperbaric ethanol antagonism in mice: studies on oxygen, nitrogen, strain and sex.

Authors:  R L Alkana; R D Malcolm
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.